Clinical Trials
16 trialsNCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT02879513 2020-03-23
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
RenJi Hospital
Phase 3 Unknown
NCT00957125 2016-09-08
PROMIX
Karolinska University Hospital
Phase 2 Unknown
NCT00002627 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003679 2013-11-06
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003680 2013-11-06
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005058 2013-11-06
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00002616 2013-09-20
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00094133 2013-09-20
Hypnosis in Treating Hot Flashes in Breast Cancer Survivors
National Cancer Institute (NCI)
Phase NA Unknown
NCT00336089 2013-09-17
Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
National Cancer Institute (NCI)
Phase NA Unknown
NCT01880385 2013-06-19
Beva
Association Tunisienne de lutte Contre le Cancer
Phase 1 Unknown
NCT01641406 2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2 Unknown
NCT01038258 2012-07-13
PETBreast
Auxilio Mutuo Cancer Center
Phase NA Unknown
NCT00891280 2011-06-15
Dose-escalation Study of Oral CX-4945
Cylene Pharmaceuticals
Phase 1 Unknown
NCT00398489 2010-11-09
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01093235 2010-03-25
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown